Browse October's selection of peer-reviewed articles from the Adis journal portfolio. Curated by the editors and updated monthly. These papers highlight topical research and reviews for the benefit of Medicine Matters readers.
ACR Convergence 2021 highlights
3–9 November: Preview the conference with session recommendations and updates on upcoming coverage.
TNF inhibitor monotherapy is associated with a lower risk for COVID-19-related hospitalization or death than other common immunomodulatory treatments given to people with immune-mediated inflammatory diseases, research suggests.
Individuals with rheumatoid arthritis have a significantly higher risk for serious infections while receiving TNF inhibitor therapy than those with psoriatic arthritis, Norwegian researchers report.
